RxDoctor Payments Data

Alisha Coulson, MD

Psychiatry · Wichita, KSNPI 1386931038

Payments from drug & device makers

$711in general payments, 2019–2025

Across 38 payments — averaging $18.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$165
  • Otsuka America Pharmaceutical, Inc.$155
  • Teva Pharmaceuticals USA, Inc.$137
  • Sunovion Pharmaceuticals Inc.$50
  • AbbVie$46
  • Vanda Pharmaceuticals Inc.$28
  • plus $130 from 8 others

What the payments were for

  • Food & beverage$711100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$711 in reported general payments places this provider in the 65th percentile of 259 psychiatry providers in Kansas.

See all psychiatry providers in Kansas

Medicare billing

Part B allowed, 2024
$13,701
Medicare patients
52
Services billed
138

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine37$199,642
Invega SustennaPaliperidone Palmitate34$109,348
IngrezzaValbenazine Tosylate12$103,583
Abilify MaintenaAripiprazole23$63,449
TrintellixVortioxetine Hydrobromide17$11,145
Lurasidone Hcl14$5,835
Aripiprazole66$5,815
Clozapine73$5,092
Duloxetine Hcl98$3,022
Paliperidone ErPaliperidone12$2,790
Divalproex Sodium ErDivalproex Sodium47$2,628
Olanzapine50$2,148
Ziprasidone Hcl22$1,776
Quetiapine Fumarate ErQuetiapine Fumarate19$1,739
Hydroxyzine Hcl49$1,582

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$137$199,64237 claims
Johnson & JohnsonInvega Sustenna$165$109,34834 claims
Neurocrine Biosciences, Inc.Ingrezza$11$103,58312 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$155$63,44923 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$18$11,14517 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 259 psychiatry providers in Kansas.

Other psychiatry in Wichita

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →